- Home
- AMZE vs OSRH Comparison
AMZE vs OSRH Comparison
Compare AMZE & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMZE | OSRH |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | 4 | 21 |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3M | 11.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AMZE | OSRH |
|---|---|---|
| Price | $0.13 | $0.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 9.0M | ★ 14.7M |
| Earning Date | 05-19-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,986.62 | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.11 | $0.38 |
| 52 Week High | $11.76 | $1.79 |
Technical Indicators
Market Signals| Indicator | AMZE | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 44.64 |
| Support Level | $0.11 | $0.44 |
| Resistance Level | $0.20 | $0.63 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 14.24 | 3.37 |
Price Performance
Historical ComparisonAbout AMZE Amaze Holdings Inc.
Amaze Holdings Inc is a software company dedicated to empowering creators by providing comprehensive software solutions and services that facilitate e-commerce, social commerce, integrated commerce selling experiences, and the distribution of a premium wine brand. The group offers an end-to-end, creator-powered commerce platform offering tools for seamless product creation, modern e-commerce solutions, and scalable managed services.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.